Clinical trials
Phase 3 Astrocytoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celtic Pharma Development Services | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Children's Oncology Group | 2 |
| Novartis Pharmaceuticals | 2 |
| Wake Forest University Health Sciences | 2 |
| Case Comprehensive Cancer Center | 1 |
| Children's Hospital Los Angeles | 1 |
| Colorado Health Foundation | 1 |
| Eastern Cooperative Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 24 |
| Brain Neoplasms | 14 |
| Central Nervous System Neoplasms | 11 |
| Glioma | 11 |
| Glioblastoma | 9 |
| Oligodendroglioma | 9 |
| Gliosarcoma | 5 |
| Choroid Plexus Neoplasms | 4 |
| Neoplasms | 4 |
| Brain Edema | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.